Erythropoietin and cancer, a double-edged sword
- PMID: 18620752
- DOI: 10.1016/j.leukres.2008.06.004
Erythropoietin and cancer, a double-edged sword
Abstract
This editorial is focused on the double controversial action of erythropoietin, acting as anticancer agent and as a promoting cancer agent.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
